Anne-Marie Duliege

2016

In 2016, Anne-Marie Duliege earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$120,205
Option Awards$604,800
Salary$358,197
Other$62,795
Total$1,145,997

Duliege received $604.8K in option awards, accounting for 53% of the total pay in 2016.

Duliege also received $120.2K in non-equity incentive plan, $358.2K in salary and $62.8K in other compensation.

Rankings

In 2016, Anne-Marie Duliege's compensation ranked 7,571st out of 14,075 executives tracked by ExecPay. In other words, Duliege earned more than 46.2% of executives.

ClassificationRankingPercentile
All
7,571
out of 14,075
46th
Division
Manufacturing
2,870
out of 5,489
48th
Major group
Chemicals And Allied Products
945
out of 1,895
50th
Industry group
Drugs
731
out of 1,538
53rd
Industry
Pharmaceutical Preparations
583
out of 1,176
50th
Source: SEC filing on March 29, 2017.

Duliege's colleagues

We found four more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2016.

2016

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2016

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2016

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2016

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like